Competitive Bidding For High-End Devices? Ways & Means Reiterates “No”
This article was originally published in The Gray Sheet
A competitive bidding model that would give physicians the discretionary ability to prescribe a particular product brand is being evaluated by the House Ways & Means Committee
You may also be interested in...
Blood glucose monitors and test strips are product areas that may fall under a competitive bidding model in upcoming Medicare reform legislation, according to device stakeholders
The passage of a Medicare prescription drug benefit in the 108th Congress could lead to the expansion of competitive bidding processes beyond durable medical equipment to include non-DME devices, consultants and industry reps are forecasting
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.